Article
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients.
The Journal of pathology - 1 Aug 2013
Stoehr Robert, Taubert Helge, Gaisa Nadine T, Smeets Daniela, Kneitz Burkhard, Giedl Johannes, Ruemmele Petra, Wieland Wolf F, Rau Tilman T, Hartmann Arndt
Abstract excerpt
Recently mutations in the MED12 gene have been reported in 5.4% of prostate tumours from Caucasian patients analysed by exome sequencing (Barbieri CE, Baca SC, Lawrence MS, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nature Genet 2012; 44: 685-...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.